TME Pharma N.V. announced a private placement to issue common share and convertible debt for the gross proceeds of ?2,700,000 on November 24, 2023.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.155 EUR | -3.00% | -11.83% | -32.61% |
06-19 | TME Pharma: in the red, a broker cuts its target | CF |
06-19 | TME PHARMA : Invest Securities reduces its target | CF |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.61% | 7.1M | |
+31.14% | 52.73B | |
+37.72% | 39B | |
-9.16% | 38.52B | |
+26.27% | 30.38B | |
-11.17% | 26.39B | |
+10.95% | 26.08B | |
+44.84% | 14.15B | |
+33.25% | 12.6B | |
-5.39% | 11.51B |
- Stock Market
- Equities
- ALTME Stock
- News TME Pharma N.V.
- TME Pharma N.V. announced that it expects to receive ?2.7 million in funding